Transmedics Group Inc
NASDAQ:TMDX 4:00:00 PM EDT
| Market Cap (Intraday) | 4.62B |
| Current PE | 94.43 |
| Forward PE | 72.83 |
| 2yr Forward PE | 52.76 |
| 10-Day MA | $132.24 |
| 50-Day MA | $118.89 |
| 200-Day MA | $96.07 |
Transmedics Group Inc Stock, NASDAQ:TMDX
200 Minuteman Road, Suite 302, Andover, Massachusetts 01810
United States of America
Phone: +1.978.552.0900
Number of Employees: 728
Description
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.